Hope O'Brien
Neurology with Special Qualifications in Child Neurology · Cincinnati, OHNPI 1972704138
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by AbbVie at 38.6% of the total. Among neurology with special qualifications in child neurology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 602 payments — averaging $871.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$203K
- Pfizer$115K
- Lilly USA, LLC$77K
- Biohaven Pharmaceuticals, Inc.$46K
- Biohaven Pharmaceutical Holding Company Ltd.$24K
- Axsome Therapeutics, Inc.$16K
- plus $45K from 20 others
Across 182 payments — averaging $2724.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$258K
- Eli Lilly$129K
- Ipsen Innovation$68K
- Merz Pharmaceuticals, LLC$34K
- Pfizer$4K
- Teva Pharmaceuticals USA, Inc.$3K
What the payments were for
- Consulting fees$153,11529%
- Speaking & faculty fees$312,29460%
- Travel & lodging$42,7748%
- Food & beverage$16,4563%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 232 | $202,683 |
| Pfizer | 96 | $114,732 |
| Lilly USA, LLC | 107 | $77,289 |
| Biohaven Pharmaceuticals, Inc. | 46 | $45,818 |
| Biohaven Pharmaceutical Holding Company Ltd. | 23 | $23,850 |
| Axsome Therapeutics, Inc. | 18 | $15,571 |
| Biodelivery Sciences International, Inc. | 14 | $12,020 |
| Amgen | 8 | $10,537 |
| Eli Lilly | 14 | $10,343 |
| Bausch Health US, LLC | 3 | $4,125 |
| Scilex Pharmaceuticals Inc. | 3 | $2,436 |
| Ipsen Biopharm Limited | 1 | $2,385 |
| Collegium Pharmaceutical, Inc. | 2 | $917 |
| Tonix Medicines, Inc. | 2 | $527 |
| Teva Pharmaceuticals USA, Inc. | 7 | $325 |
| SK Life Science, Inc. | 6 | $263 |
| AstraZeneca | 2 | $210 |
| Lundbeck LLC | 5 | $179 |
| Janssen Scientific Affairs, LLC | 1 | $130 |
| Gynesonics, Inc. | 1 | $124 |
| Impel Pharmaceuticals LLC | 3 | $56 |
| Impel Pharmaceuticals Inc. | 3 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$123,174
- UBRELVY$115,304
- QULIPTA$109,955
- ZAVZPRET$35,984
- Symbravo$15,415
- ELYXYB - CELECOXIB$15,018
- EMGALITY$14,914
- AIMOVIG$10,504
- BOTOX$6,064
- DYSPORT$2,385
- ZEMBRACE SYMTOUCH$500
- XELJANZ$154
- Tremfya$130
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$124
- SOLIRIS$118
- XCOPRI$115
- AJOVY$105
How this compares
$524,674 in reported general payments places this provider in the 95th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Other neurology with special qualifications in child neurology in Cincinnati
- Tracy GlauserCincinnati$130K
- Cuixia TianCincinnati$91K
- Shannon StandridgeCincinnati$79K
- Darcy KruegerCincinnati$45K
- Andrew HersheyCincinnati$36K
- Susan FongCincinnati$32K
- Donald GilbertCincinnati$19K
- Marielle SamahaCincinnati$12K
- Gewalin AungaroonCincinnati$8K
- Steven WuCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.